Details about Farasat A.S. Bokhari

Access statistics for papers by Farasat A.S. Bokhari.

Last updated 2024-10-09. Update your information in the RePEc Author Service.

Short-id: pbo33

Working Papers

2024

1. A Comment on Sampson (2023)
   I4R Discussion Paper Series, The Institute for Replication (I4R)

2022

2. Banning Volume Discounts to Curb Excessive Consumption: A Cautionary Tale
   Working Paper series, University of East Anglia, Centre for Competition Policy (CCP), Centre for Competition Policy, University of East Anglia, Norwich, UK.
   See also Journal Article Banning volume discounts to curb excessive consumption: A cautionary tale, European Economic Review, Elsevier (2023) View citations (1) (2023)

2020

3. Entry limiting agreements: First mover advantage, authorized generics and pay-for-delay deals
   Working Paper series, University of East Anglia, Centre for Competition Policy (CCP), Centre for Competition Policy, University of East Anglia, Norwich, UK.
   See also Journal Article Entry limiting agreements: First‐mover advantage, authorized generics, and pay‐for‐delay deals, Journal of Economics & Management Strategy, Wiley Blackwell (2020) (2020)
4. Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market
   Papers, Economic and Social Research Institute (ESRI) View citations (1)
   Also in Working Paper series, University of East Anglia, Centre for Competition Policy (CCP), Centre for Competition Policy, University of East Anglia, Norwich, UK. (2020) View citations (1)

2019

5. Balancing Environmental Incentives and Fairness in Household Electricity Distribution Tariffs
   Working Paper series, University of East Anglia, Centre for Competition Policy (CCP), Centre for Competition Policy, University of East Anglia, Norwich, UK. View citations (1)
6. Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions
   Working Paper series, University of East Anglia, Centre for Competition Policy (CCP), Centre for Competition Policy, University of East Anglia, Norwich, UK.
   See also Journal Article Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions, Small Business Economics, Springer (2021) View citations (1) (2021)

2018

7. Demand estimation and merger simulations for drugs: Logits v. AIDS
   Working Paper series, University of East Anglia, Centre for Competition Policy (CCP), Centre for Competition Policy, University of East Anglia, Norwich, UK. View citations (2)
   See also Journal Article Demand estimation and merger simulations for drugs: Logits v. AIDS, International Journal of Industrial Organization, Elsevier (2018) View citations (1) (2018)

2016

8. Assessing the impact of health care expenditures on mortality using cross-country data
   Working Papers, Centre for Health Economics, University of York View citations (3)
   See also Chapter Assessing the Impact of Health Care Expenditures on Mortality Using Cross-Country Data, World Scientific Book Chapters, World Scientific Publishing Co. Pte. Ltd. (2020) (2020)

2013

9. What is the price of pay-to-delay deals?
   Working Paper series, University of East Anglia, Centre for Competition Policy (CCP), Centre for Competition Policy, University of East Anglia, Norwich, UK. View citations (3)
   See also Journal Article WHAT IS THE PRICE OF PAY-TO-DELAY DEALS?, Journal of Competition Law and Economics, Oxford University Press (2013) View citations (3) (2013)

2009

10. Entry in the ADHD drugs market: Welfare impact of generics and me-toos
    Working Papers, Department of Economics, Florida State University View citations (12)
    See also Journal Article Entry in the ADHD drugs market: Welfare impact of generics and me-too's, Journal of Industrial Economics, Wiley Blackwell (2013) View citations (23) (2013)
11. School accountability laws and the consumption of psychostimulants
    Working Papers, Department of Economics, Florida State University
    See also Journal Article School accountability laws and the consumption of psychostimulants, Journal of Health Economics, Elsevier (2011) View citations (17) (2011)

2006

12. Government Health Expenditures and Health Outcomes
    Working Papers, Department of Economics, Florida State University View citations (6)
    See also Journal Article Government health expenditures and health outcomes, Health Economics, John Wiley & Sons, Ltd. (2007) View citations (102) (2007)
13. Managed Care and the Adoption of Hospital Technology: The Case of Cardiac Catherterization
    Working Papers, Department of Economics, Florida State University
    Also in HEW, University Library of Munich, Germany (2001) View citations (4)

2004

14. An analysis of the significant variation in psychostimulant use across the U.S
    Working Papers, Department of Economics, Florida State University

1998

15. Returns to Specialization, Transaction Costs, and the Dynamics of Industry Evolution
    Industrial Organization, University Library of Munich, Germany View citations (1)

1996

16. Optimum Population -- A New Look: A Hamiltonian Approach Towards A Dynamic Analysis
    Labor and Demography, University Library of Munich, Germany

Journal Articles

2024

1. Antibacterial resistance and the cost of affecting demand: The case of UK antibiotics
   International Journal of Industrial Organization, 2024, 95, (C)
2. Discrimination in healthcare: A field experiment with Pakistan's transgender community
   Labour Economics, 2024, 87, (C)
3. Lockdown drinking: The sobering effect of price controls in a pandemic
   Economic Inquiry, 2024, 62, (4), 1539-1557

2023

4. Banning volume discounts to curb excessive consumption: A cautionary tale
   European Economic Review, 2023, 156, (C) View citations (1)
   See also Working Paper Banning Volume Discounts to Curb Excessive Consumption: A Cautionary Tale, Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) (2022) (2022)

2021

5. Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions
   Small Business Economics, 2021, 57, (1), 603-634 View citations (1)
   See also Working Paper Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions, Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) (2019) (2019)

2020

6. Entry limiting agreements: First‐mover advantage, authorized generics, and pay‐for‐delay deals
   Journal of Economics & Management Strategy, 2020, 29, (3), 516-542
   See also Working Paper Entry limiting agreements: First mover advantage, authorized generics and pay-for-delay deals, Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) (2020) (2020)

2018

7. Demand estimation and merger simulations for drugs: Logits v. AIDS
   International Journal of Industrial Organization, 2018, 61, (C), 653-685 View citations (1)
   See also Working Paper Demand estimation and merger simulations for drugs: Logits v. AIDS, Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) (2018) View citations (2) (2018)

2014

8. Selective admission into stroke unit and patient outcomes: a tale of four cities
   Health Economics Review, 2014, 4, (1), 1-10

2013

9. Entry in the ADHD drugs market: Welfare impact of generics and me-too's
   Journal of Industrial Economics, 2013, 61, (2), 339-392 View citations (23)
   See also Working Paper Entry in the ADHD drugs market: Welfare impact of generics and me-toos, Working Papers (2009) View citations (12) (2009)
10. WHAT IS THE PRICE OF PAY-TO-DELAY DEALS?
    Journal of Competition Law and Economics, 2013, 9, (3), 739-753 View citations (3)
    See also Working Paper What is the price of pay-to-delay deals?, Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) (2013) View citations (3) (2013)

2011

11. School accountability laws and the consumption of psychostimulants
    Journal of Health Economics, 2011, 30, (2), 355-372 View citations (17)
    See also Working Paper School accountability laws and the consumption of psychostimulants, Working Papers (2009) (2009)

2009

12. Managed care competition and the adoption of hospital technology: The case of cardiac catheterization
    International Journal of Industrial Organization, 2009, 27, (2), 223-237 View citations (14)

2007

13. Government health expenditures and health outcomes
    Health Economics, 2007, 16, (3), 257-273 View citations (102)
    See also Working Paper Government Health Expenditures and Health Outcomes, Working Papers (2006) View citations (6) (2006)
14. OPEN VERSUS CLOSED FIRMS AND THE DYNAMICS OF INDUSTRY EVOLUTION*
    Journal of Industrial Economics, 2007, 55, (3), 499-527 View citations (9)

Chapters

2020

1. Assessing the Impact of Health Care Expenditures on Mortality Using Cross-Country Data
   Chapter 1 in Global Health Economics Shaping Health Policy in Low- and Middle-Income Countries, 2020, pp 3-49
   See also Working Paper Assessing the impact of health care expenditures on mortality using cross-country data, Centre for Health Economics, University of York (2016) View citations (3) (2016)